NR3C2 (Mineralocorticoid Receptor) antagonists improve outcomes in patients with chronic heart failure caused by LV systolic dysfunction and hypertension by minimizing the cardiovascular damages88, 89. This evidence concerns the gene NR3C2 and congestive heart failure.